Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2007;119(11):379–384. doi: 10.1007/s00508-007-0810-7

Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl

Letale Mykoplasmenpneumonie bei einer 18-jährigen Patientin ohne bekannte Risikofaktoren

Florian Daxboeck 1,✉, Bernhard Eisl 2, Christofer Burghuber 2, Mazda Memarsadeghi 3, Ojan Assadian 1, Gerold Stanek 4
PMCID: PMC7102288  PMID: 17634897

Summary

A case of fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl is reported. On hospital day 9, the antibody titer to M. pneumoniae was 1:512 in the complement fixation test and 1:5120 in the microparticle agglutination assay. After five weeks in the intensive care unit, the patient died from necrotizing hemorrhagic pneumonia with multi-organ failure. No significant superinfections occurred during ICU treatment. Corticosteroids (hospital day 8 onward) did not influence the course of the disease. It is noteworthy that, as in some previously reported cases, the clinical state deteriorated during presumably adequate antibiotic treatment (2 days before admission onward), and despite documented eradication of the pathogen from the respiratory tract (PCR from bronchoalveolar fluid on hospital day 22 was negative). However, the illness had lasted for several days before admission to the hospital, therefore the potentially beneficial effect of antibiotic treatment at an early stage of the disease cannot be assessed. Clearly, in default of other treatment options, correct diagnosis and early treatment of mycoplasma community-acquired pneumonia seems mandatory. This is the third case of fatal mycoplasma pneumonia reported from Austria in recent years, making this topic worthy of further scientific attention.

Keywords: Mycoplasma pneumoniae, Necrotizing pneumonia, Multi-organ failure

References

  1. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17(Suppl 1):S37–S46. doi: 10.1093/clinids/17.supplement_1.s37. [DOI] [PubMed] [Google Scholar]
  2. Daxboeck F, Bauer CC, Assadian O, Stanek G. An unrecognized Mycoplasma pneumoniae epidemic in Vienna. Wien Klin Wochenschr. 2006;118:208–211. doi: 10.1007/s00508-005-0469-x. [DOI] [PubMed] [Google Scholar]
  3. Clyde WA., Jr Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis. 1993;17(Suppl 1):S32–S36. [PubMed] [Google Scholar]
  4. Denny FW, Clyde WA, Jr, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis. 1971;123:74–92. doi: 10.1093/infdis/123.1.74. [DOI] [PubMed] [Google Scholar]
  5. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728. doi: 10.1128/CMR.17.4.697-728.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chan ED, Kalayanamit T, Lynch DA, Tuder R, Arndt P, Winn R, Schwarz MI. Mycoplasma pneumoniae-associated bronchiolitis causing severe restrictive lung disease in adults. Chest. 1999;115:1188–1194. doi: 10.1378/chest.115.4.1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Prabhu MB, Barber D, Cockcroft DW. Bronchiolitis obliterans and Mycoplasma pneumonia. Respir Med. 1991;85:535–537. doi: 10.1016/S0954-6111(06)80274-X. [DOI] [PubMed] [Google Scholar]
  8. Llibre JM, Urban A, Garcia E, Carrasco MA, Murcia C. Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin Infect Dis. 1997;25:1340–1342. doi: 10.1086/516124. [DOI] [PubMed] [Google Scholar]
  9. Van Bever HP, Van Doorn JWD, Demey HE. Adult respiratory distress syndrome associated with Mycoplasma pneumoniae infection. Eur J Pediatr. 1992;151:227–228. doi: 10.1007/BF01954392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis. 2000;31:1507–1511. doi: 10.1086/317498. [DOI] [PubMed] [Google Scholar]
  11. Oermann C, Sockrider MM, Langston C. Severe necrotizing pneumonitis in a child with Mycoplasma pneumoniae infection. Pediatr Pulmonol. 1997;24:61–65. doi: 10.1002/(SICI)1099-0496(199707)24:1<61::AID-PPUL11>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  12. Daxböck F, Brunner G, Popper H, Krause R, Schmid K, Krejs GJ, Wenisch C. A case of lung transplantation following Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis. 2002;21:318–322. doi: 10.1007/s10096-002-0698-0. [DOI] [PubMed] [Google Scholar]
  13. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med. 1995;162:133–142. [PMC free article] [PubMed] [Google Scholar]
  14. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9:263–273. doi: 10.1046/j.1469-0691.2003.00590.x. [DOI] [PubMed] [Google Scholar]
  15. Takiguchi Y, Shikama N, Aotsuka N, Koseki H, Terano T, Hirai A. Fulminant Mycoplasma pneumoniae pneumonia. Intern Med. 2001;40:345–348. doi: 10.2169/internalmedicine.40.345. [DOI] [PubMed] [Google Scholar]
  16. Chian CF, Chang FY. Acute respiratory distress syndrome in Mycoplasma pneumonia: a case report and review. J Microbiol Immunol Infect. 1999;32:52–56. [PubMed] [Google Scholar]
  17. Baum H, Strubel A, Nollert J, Layh-Schmitt G. Two cases of fulminant Mycoplasma pneumoniae pneumonia within 4 months. Infection. 2000;28:180–183. doi: 10.1007/s150100050077. [DOI] [PubMed] [Google Scholar]
  18. Turi L, Herbecq P, Vignozzi G, Lemaire C. Respiratory distress syndrome in an adult secondary to Mycoplasma pneumoniae infection. Presse Med. 1996;25:127. [PubMed] [Google Scholar]
  19. Graninger W (2005) Tödliche Mykoplasmenpneumonie mit Multi-Organ-Versagen. 8. Kongress für Infektionskrankheiten und Tropenmedizin, Hamburg, S57
  20. Cassell GH. Severe Mycoplasma disease – rare or underdiagnosed? West J Med. 1995;162:172–175. [PMC free article] [PubMed] [Google Scholar]
  21. Lieberman D, Schlaeffer F, Lieberman D, Horowitz S, Horovitz O, Porath A. Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration. 1996;63:261–266. doi: 10.1159/000196557. [DOI] [PubMed] [Google Scholar]
  22. Daxboeck F, Gattringer R, Mustafa S, Bauer C, Assadian O. Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect. 2005;11:507–510. doi: 10.1111/j.1469-0691.2005.01154.x. [DOI] [PubMed] [Google Scholar]
  23. Jacobs E. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infect Dis. 1993;17(Suppl 1):S79–S82. doi: 10.1093/clinids/17.supplement_1.s79. [DOI] [PubMed] [Google Scholar]
  24. Barker CE, Sillis M, Wreghitt TG. Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mucapture ELISA and indirect immunofluorescence. J Clin Pathol. 1990;43:163–165. doi: 10.1136/jcp.43.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wubbel L, Jafri HS, Olsen K, Shelton S, Barton Rogers B, Gambill G, et al. Mycoplasma pneumoniae pneumonia in a mouse model. J Infect Dis. 1998;178:1526–1529. doi: 10.1086/314439. [DOI] [PubMed] [Google Scholar]
  26. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpaa R, Mertsola J, Ruuskanen O. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol. 1998;36:3155–3159. doi: 10.1128/jcm.36.11.3155-3159.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tjhie JHT, van Kuppefeld FJM, Roosendaal R, Melchers WJ, Gordijn R, MacLaren DM, Walboomers JM, Meijer CJ, van den Brule AJ. Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections. J Clin Microbiol. 1994;32:11–16. doi: 10.1128/jcm.32.1.11-16.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dorigo-Zetsma JW, Zaat SA, Vriesema AJ, Dankert J. Demonstration by a nested PCR for Mycoplasma pneumoniae that M. pneumoniae load in the throat is higher in patients hospitalised for M. pneumoniae infection than in non-hospitalised subjects. J Med Microbiol. 1999;48:1115–1122. doi: 10.1099/00222615-48-12-1115. [DOI] [PubMed] [Google Scholar]
  29. Opitz O, Piestch K, Ehlers S, Jacobs E. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology. 1996/1997;196:575–587. doi: 10.1016/s0171-2985(97)80073-3. [DOI] [PubMed] [Google Scholar]
  30. Fernald GW. Role of host response in Mycoplasma pneumoniae disease. J Infect Dis. 1973;127(Suppl):S55–S58. doi: 10.1093/infdis/127.supplement_1.s55. [DOI] [PubMed] [Google Scholar]
  31. Pietsch K, Jacobs E. Characterization of the cellular response of spleen cells in BALB/c mice inoculated with Mycoplasma pneumoniae or the P1 protein. Med Microbiol Immunol (Berl) 1993;182:77–85. doi: 10.1007/BF00189375. [DOI] [PubMed] [Google Scholar]
  32. Ito S, Abe Y, Kinomoto K, Saitoh T, Kato T, Kohli Y, Kuriyama M, Sakai T, Ishizaki T. Fulminant Mycoplasma pneumoniae pneumonia with marked elevation of serum soluble interleukin-2 receptor. Intern Med. 1995;34:430–435. doi: 10.2169/internalmedicine.34.430. [DOI] [PubMed] [Google Scholar]
  33. Tanaka H, Honma S, Abe S, Tamura H. Effects of interleukin-2 and cyclosporine A on pathologic features in Mycoplasma pneumonia. Am J Respir Crit Care Med. 1996;154:1908–1912. doi: 10.1164/ajrccm.154.6.8970385. [DOI] [PubMed] [Google Scholar]
  34. Foy HM, Ochs H, Davis SD, Kenny GE, Luce RR. Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis. 1973;127:388–393. doi: 10.1093/infdis/127.4.388. [DOI] [PubMed] [Google Scholar]
  35. Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol. 2005;43:2277–2285. doi: 10.1128/JCM.43.5.2277-2285.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Wiener Klinische Wochenschrift are provided here courtesy of Nature Publishing Group

RESOURCES